Drug profile · INN
idarucizumab
PRAXBIND
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
idarucizumab (PRAXBIND) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN idarucizumab
Brand PRAXBIND
Route INJECTION
Formulation INJECTABLE
ATC code V03AB
Frequently asked questions
What is idarucizumab?
idarucizumab (PRAXBIND) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for idarucizumab?
PRAXBIND is a marketed brand name for idarucizumab. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of idarucizumab?
idarucizumab has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.